BPC-157 & TB-500 Blend (Research-Grade Peptides)

Regenerative peptide combination — for laboratory research only

Product Overview

The BPC-157 and TB-500 blend combines two widely studied research peptides with potential
roles in tissue repair and recovery. BPC-157 (Body Protection Compound 157)
is a synthetic peptide fragment derived from a gastric protein, while
TB-500 (Thymosin Beta-4 fragment) is a synthetic sequence associated with
actin regulation. Together, they are provided here as a
research-grade formulation for preclinical and laboratory investigation
into regenerative pathways.

Research Highlights

• Tissue Repair Studies: BPC-157 has been explored in animal models for
  potential effects on tendon, ligament, and gastrointestinal tissue recovery.
  PubMed
• Angiogenesis & Cell Migration: TB-500 has been studied for its
  involvement in angiogenesis, wound healing, and cell migration mechanisms.
  PubMed
• Synergistic Investigations: Preclinical interest exists in combining
  these peptides to better understand overlapping regenerative and cytoprotective pathways.
• Ongoing Areas of Study: Research continues on their potential
  applications in musculoskeletal recovery, inflammation modulation, and vascular biology.

Product Details & Handling

• Form: Lyophilized peptide powder, sterile vials
• Purity: ≥ 98% (Certificate of Analysis provided)
• Storage: Store at –20 °C; protect from light and moisture
• Handling: Laboratory use only with appropriate PPE;
  consult SDS for full safety guidance

Legal Disclaimer

This product is provided strictly for laboratory research use only.
It is not intended for human or veterinary consumption, therapeutic, diagnostic,
or clinical application. Customers are responsible for ensuring compliance with applicable
laws and institutional requirements. The BPC-157/TB-500 blend is
not approved by the FDA in research form, and Windy City Peptide does not
provide medical advice or support for human use.